a Experimental Oncology, Istituto Tumori G. Paolo II, IRCCS, Bari, Italy; b Department of Medical and Surgical Sciences and Biotechnology, University of Rome la Sapienza, Latina, Italy; c Division of… Click to show full abstract
a Experimental Oncology, Istituto Tumori G. Paolo II, IRCCS, Bari, Italy; b Department of Medical and Surgical Sciences and Biotechnology, University of Rome la Sapienza, Latina, Italy; c Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy; d Breast Oncology and Clinical Trials Education, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA; e Medical Oncology Department, Centre Léon-Bérard, Lyon, France Received: September 8, 2021 Accepted: September 10, 2021 Published online: September 29, 2021
               
Click one of the above tabs to view related content.